Industry Analyst Nandhini Rajajgopal has completed extensive analysis on the North American Oral Solid Drug Dosage Excipients Market. The expert will lead a short teleconference about new findings that affect the market, followed by a live question-and-answer session.
You Will Discover:
Blockbuster drugs worth $73,850 million are expected to lose patent protection in the United States between 2009 and 2017, resulting in an influx of generic manufacturers. This briefing will investigate the increase in volume of drugs and the relative increase in excipients volume.
Why you should attend?
- Understand the different types of excipients used in solid drug dosage forms, their price, current market size and future market scenario.
- Learn key unmet needs and success factors for oral solid drug dosage excipients.
- Identify the drivers and restraints of the market.
Click on the "Attend" button below to register for this event.